EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.391
https://www.valueinhealthjournal.com/article/S1098-3015(23)03521-0/fulltext
Title : EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03521-0&doi=10.1016/j.jval.2023.09.391
First page :
Section Title :
Open access? : No
Section Order : 12418
Categories :
Tags :
Regions :
ViH Article Tags :